-
Uncategorized1 day ago
Biotech Looks to Replimune RP1 Decision as ‘First Indicator’ of FDA Direction
Biotech Looks to Replimune RP1 Decision as ‘First Indicator’ of FDA Direction
-
Uncategorized1 day ago
FDA Reversals in Rare Disease Space Highlight Confusion Around External Controls
While recent FDA guidance speaks to the agency’s support of innovative trial designs—including the use of external controls—the application of this flexibility appears to be inconsistent....
-
Uncategorized1 day ago
StockWatch: Price War Dampens Lilly Surge After Oral GLP-1 Wins FDA Nod
Eli Lilly (NYSE: LLY) won the approval it sought when the FDA authorized the company’s oral obesity drug Foundayo (orforglipron), but the pharma giant’s post-approval stock...
-
Uncategorized2 days ago
AI model designs new treatment candidate for opioid addiction that cuts cravings in rats
While the opioid epidemic is one of the most urgent public health emergencies facing the U.S., new therapeutic approaches for treating the underlying substance use disorder...
-
Uncategorized3 days ago
Pharma’s dealmaking tear; Blackstone raises record fund; Xolair energizes allergy research; and more
Welcome back to Endpoints Weekly! They say March comes in like a lion and out like a lamb, but two pharma giants made a roar this...
-
Uncategorized3 days ago
Gungnir codec enabling high error-tolerance and low-redundancy DNA storage through substantial computing power
Post Content
-
Uncategorized4 days ago
Injectable Microgel Developed to Reduce Bleeding in Infants Undergoing Surgery
Biomedical researchers headed by a team at the Lampe Joint Department of Biomedical Engineering, University of North Carolina at Chapel Hill/North Carolina State University, have developed...
-
Uncategorized4 days ago
Epigenetic Strategy Restores Tumor Suppressor in Acute Myeloid Leukemia Models
Scientists from The Jackson Laboratory (JAX) and their collaborators elsewhere have found a potential way to treat cases of acute myeloid leukemia that involves turning a...
-
Uncategorized4 days agoSTAT+: NIH would get $5 billion cut under Trump’s 2027 budget, but Congress unlikely to go along
The White House is asking Congress to cut $5 billion from the National Institutes of Health and to downsize the number of its institutes and centers...
-
Uncategorized4 days agoTrump revives pharma tariffs with 100% charges, but leaves loopholes
“Section 232” national security levies won’t apply to a wide array of drugs, meaning the “overall threat to the sector should be low,” according to one...
Microplastics in Human Bile Drive Mitochondrial Dysfunction and Senescence
STAT+: Health insurers score major win with higher 2027 Medicare Advantage rates
